$377.52−$1.79 (-0.47%)as of market close, Jul 24, 2026
ELV — Elevance Health Inc. stock price, chart and key statistics
Key stats
Price data
- Price
- $377.52
- Change YTD
- +6.57%
- Market cap
- 81.9B
- Enterprise value
- 102.3B
- Shares outstanding
- 216.9M
- 52W low
- $273.71
- 52W high
- $436.24
- From 52W high
- -13.46%
- From 52W low
- +37.93%
- 52W range
- 64%
- Beta
- 0.68
Volume
- Rel volume
- 0.72×
- 30D volume
- 1.7M
- 30D $ vol
- 660.6M
Fundamentals
- Sales (ttm)
- 201.1B
- Sales/share
- $927.35
- EPS (ttm)
- $22.78
- FCF (ttm)
- 6.3B
- FCF/share
- $29.00
- Book value/share
- $206.96
- Net margin
- 2.47%
- ROE
- 11.06%
- ROA
- 3.93%
- Debt / equity
- 0.68×
- Current ratio
- 1.52
Growth (CAGR, ttm) · 10Y
- Sales
- +9.41%
- Net income
- +7.91%
- FCF
- +8.59%
- Shares
- -1.92%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +10.17%
- Sales/share
- +11.55%
- FCF/share
- +10.71%
- Book value/share
- +8.44%
- Dividend/share
- +10.40%
- Price
- +10.19%
- Total return
- +11.68%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 16.5×
- Fwd P/E
- 12.8×
- P/S (ttm)
- 0.4×
- P/B (mrq)
- 1.8×
- P/FCF (ttm)
- 13.0×
- EV/EBITDA (fy)
- 11.7×
- EV/Sales (ttm)
- 0.5×
- FCF yield (ttm)
- 7.68%
- Dividend yield (fwd)
- 1.82%
- Dividend/share (fwd)
- $6.88
- Buyback yield (ttm)
- 3.30%
- Shareholder yield (ttm)
- 5.14%
Vs own 10Y history
- P/E
- 44th
- P/S
- 9th
- P/B
- 17th
- P/FCF
- 36th
Bar = where today's multiple sits in ELV's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance
1D
-0.47%
1W
+1.18%
1M
-1.69%
3M
+9.02%
YTD
+6.57%
1Y
+27.28%
5Y
-4.08%
Financial statements
Open full ELV financials →Related Healthcare
1MElevance Health Inc. (ELV) trades at $377.52 with a live price and an interactive chart covering 24+ years of daily price history, plus key valuation metrics. ChartRow also publishes ELV's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full ELV financial statements →